InflammaDry® is the only rapid, in-practice test to aid in dry eye diagnosis
Identifying Dry Eye
Inflammation is linked to dry eye and is present in both symptomatic and asymptomatic patients.1 Elevated MMP-9 levels act as a biomarker for inflammation and is more sensitive at detection than clinical signs alone.2
InflammaDry® recognises elevated levels of MMP-9 to identify patients that may otherwise be missed with other dry eye testing methods. InflammaDry® is the first and only, rapid, in-practice test that detects MMP-9, an inflammatory marker that is consistently elevated in the tears of patients with Dry Eye Disease. Commit to making the right diagnosis with an easy-to-use, in-practice, dry eye test that gives accurate results in as little as 10 minutes.
By identifying and treating patients with dry eye, pre-surgical measurements are more accurate and post surgical outcomes are improved. It also reduces post-surgical complications, such as corneal wound healing, by identifying dry eye prior to surgery. And the therapeutic treatment of dry eye will improve patient quality of life.
What makes InflammaDry unique
Get the right diagnosis
Find out how to use InflammaDry for the best results by watching this demonstration or reading the instructions.
Read the news on
Find out more about this event here. Date: 24-25 June 2022 Location: Hard Rock Hotel LondonGreat Cumberland PlaceLondonW1H…
An innovative company delivering the latest developments in Optometry, Ophthalmology, Dispensing, Contact lenses and Business/Marketing.
SightCare Business & Networking Conference for Independent Optical Practices.
Interested in using InflammaDry in your practice?
Contact us to find out more about InflammaDry and to order.
1.M.D.P. Willcox et al. The Ocular Surface. TFOS DEWS II Tear Film Report. 15 (2017) 366e403
2.Kaufman H. The practical detection of mmp-9 diagnoses ocular surface disease and may help prevent its complications. Cornea 2013;32:211–216